Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | 0.27 | 6e-15 |
mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.25 | 5e-14 |
mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | 0.26 | 3e-12 |
mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.22 | 1e-10 |
mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | 0.22 | 5e-10 |
mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | 0.22 | 9e-08 |
mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-06 |
mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | 0.16 | 8e-06 |
mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | 0.15 | 1e-05 |
mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-05 |